Alcazar Capital logo

Alcazar Capital

Asia, Dubai, United Arab Emirates, Dubai

Description

Alcazar Capital Limited is an Investments Advisory Firm based in Dubai International Financial Center.

Investor Profile

Alcazar Capital has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Series C (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Air Transportation
  • Artificial Intelligence (Ai)
  • Augmented Reality
  • Information Technology
  • Biotechnology
  • Industrial Automation
  • Medical
  • Robotics
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alcazar Capital frequently co-invest with?

Lockheed Martin Ventures
North America, Maryland, United States, Bethesda
Co-Investments: 1
Co-Investments: 1
Co-Investments: 1
Green D Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 1
IronGate Capital Advisors
North America, Florida, United States, Palm Beach Gardens
Co-Investments: 1
AH
North America, Florida, United States, Boca Raton
Co-Investments: 1
Florida Opportunity Fund
North America, Florida, United States, Orlando
Co-Investments: 1
Alpha Edison
North America, California, United States, Los Angeles
Co-Investments: 1
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 2
Alliance Holdings GP
North America, Oklahoma, United States, Tulsa
Co-Investments: 1

What are some of recent deals done by Alcazar Capital?

RED 6

Orlando, Florida, United States

RED 6 is an augmented reality company that works with the Air Force to train fighter pilots.

Air TransportationArtificial Intelligence (AI)Augmented RealityInformation Technology
Series BJun 2, 2023
Amount Raised: $70,000,000
Emerald Cloud Lab

Austin, Texas, United States

Emerald Cloud Lab is building technology platforms to drive the future of biotechnology innovation.

BiotechnologyIndustrial AutomationMedicalRoboticsTherapeutics
Series CApr 19, 2019